Skip to Main Content
Article navigation

Bibliometric traits were used to describe the development and clinical use of levodopa as an antiparkinsonian agent. Yearly percent compositions of a complete collection of 2,335 papers, published from 1960 through 1974, which reported the administration of levodopa to humans, were obtained for: single‐author, non‐regular‐journal, DOPA‐word in title, short, O reference, English language, and contemporary papers. From this basic description a hypothesis was erected, according to which these bibliometric traits can be used for predicting the future of a developing drug. A successful drug (a drug of choice) will have a development peak and a clinical‐use peak on a graph plotting the annual slopes of the percent composition of the trait against the year, for ‘bursts’ of 3–6 years. The main premonitory event (predictor) is the switch in polarity of the slope. Single‐author papers were judged to be the best bibliometric trait for predictive use.

This content is only available via PDF.
You do not currently have access to this content.
Don't already have an account? Register

Purchased this content as a guest? Enter your email address to restore access.

Please enter valid email address.
Email address must be 94 characters or fewer.
Pay-Per-View Access
$41.00
Rental

or Create an Account

Close Modal
Close Modal

Gift article access

As a benefit of your subscription, you can share temporary access to restricted articles.

Each link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.

Please sign in to your personal account to gift article access.

Register

Gift article access

As a benefit of your subscription, you can share temporary access to restricted articles.

Each link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.

Gift articles remaining: --

Gift article access

Each link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.

Gift articles remaining: --

Gift article access

As a benefit of your subscription, you can share temporary access to restricted articles.

Each link will stop working after 30 days or 10 uses.

You have reached the limit of 10 links within a 30 day period.